There are 3484 resources available
Detection of HPV circulating tumour DNA
Presenter: Scott Bratman
Session: Liquid biopsies development and application: Where do we stand?
Resources:
Slides
Webcast
Presentation of case/condition
Presenter: Olivier Casasnovas
Session: A young female with limited stage classic Hodgkin’s lymphoma and large mediastinal mass
Resources:
Slides
Webcast
EBCP and implementation plans at the EU level
Presenter: Philippe Roux
Session: Transnational cancer policies: EU and WHO projects driving improvements in national cancer plans
Resources:
Slides
Webcast
How to select the chemotherapy
Presenter: Peter Borchmann
Session: A young female with limited stage classic Hodgkin’s lymphoma and large mediastinal mass
Resources:
Slides
Webcast
Multi-arm multi-stage (MAMS) trials
Presenter: Mahesh Parmar
Session: More intelligent trial design
Resources:
Slides
Webcast
Early breast cancer case discussion
Presenter: Sibylle Loibl
Session: ESMO Clinical Practice Guidelines 1
Resources:
Slides
Webcast
LBA83 - Neoadjuvant chemotherapy with FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy for borderline resectable and resectable pancreatic cancer (PREOPANC-2): A multicenter randomized controlled trial
Presenter: Bas Groot Koerkamp
Session: Proffered Paper session 2 - Gastrointestinal tumours, upper digestive
Resources:
Abstract
Slides
Webcast
2362MO - Erdafitinib (erda) vs chemotherapy (chemo) in patients (pts) with advanced or metastatic urothelial cancer (mUC) with select FGFR alterations (FGFRalt): Subgroups from the phase III THOR study
Presenter: Yohann Loriot
Session: Mini oral session - Genitourinary tumours, non-prostate
Resources:
Abstract
Slides
Webcast
740MO - Dostarlimab + chemotherapy for the treatment of primary advanced or recurrent endometrial cancer (pA/rEC): Analysis of progression free survival (PFS) and overall survival (OS) outcomes by molecular classification in the ENGOT-EN6-NSGO/GOG-3031/RUBY trial
Presenter: Mansoor Raza Mirza
Session: Mini oral session - Gynaecological cancers
Resources:
Abstract
Slides
Webcast
Next generation imaging: How does it change the evidence seen in trials?
Presenter: Bertrand Tombal
Session: Dissecting metastatic castration-sensitive prostate cancer (mCSPC) for optimal patient benefit
Resources:
Slides
Webcast